0001179110-14-015514.txt : 20141016 0001179110-14-015514.hdr.sgml : 20141016 20141015180946 ACCESSION NUMBER: 0001179110-14-015514 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141010 FILED AS OF DATE: 20141015 DATE AS OF CHANGE: 20141015 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001070081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043416587 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 BUSINESS PHONE: 9082227000 MAIL ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 FORMER COMPANY: FORMER CONFORMED NAME: PTC THERAPEUTICS INC DATE OF NAME CHANGE: 19980909 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hirawat Claudia de Oliveira Ribeiro CENTRAL INDEX KEY: 0001578990 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35969 FILM NUMBER: 141158446 MAIL ADDRESS: STREET 1: PTC THERAPEUTICS, INC. STREET 2: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080 4 1 edgar.xml FORM 4 - X0306 4 2014-10-10 0 0001070081 PTC THERAPEUTICS, INC. PTCT 0001578990 Hirawat Claudia de Oliveira Ribeiro C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080 0 1 0 0 President Common Stock 2014-10-10 4 M 0 38333 10.85 A 73070 D Common Stock 2014-10-10 4 M 0 8750 10.85 A 81820 D Common Stock 2014-10-10 4 S 0 43489 36.18 D 38331 D Common Stock 2014-10-15 4 M 0 2395 10.85 A 40726 D Common Stock 2014-10-15 4 S 0 1872 35.36 D 38854 D Common Stock 2014-10-15 4 S 0 300 36.09 D 38554 D Common Stock 194 I By Spouse Stock Option (right to buy) 10.85 2014-10-10 4 M 0 38333 0 D 2023-05-15 Common Stock 38333 76667 D Stock Option (right to buy) 10.85 2014-10-10 4 M 0 8750 0 D 2023-05-15 Common Stock 8750 11250 D Stock Option (right to buy) 10.85 2014-10-15 4 M 0 2395 0 D 2023-05-15 Common Stock 2395 74272 D The transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $36.00 to $36.46 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 15, 2014. This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on January 31, 2014. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $35.00 to $35.96 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $36.01 to $36.24 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. /s/ Colleen Diver Johnson, attorney-in-fact 2014-10-15